AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $12,630,000 | +1304.9% | 14,068,000 | +1123.3% | 2.74% | +684.3% |
Q2 2020 | $899,000 | +2.4% | 1,150,000 | 0.0% | 0.35% | -29.7% |
Q1 2020 | $878,000 | -91.2% | 1,150,000 | -90.3% | 0.50% | -90.1% |
Q4 2019 | $10,012,000 | +29.5% | 11,900,000 | +26.6% | 5.02% | +14.5% |
Q3 2019 | $7,732,000 | -15.5% | 9,400,000 | -17.5% | 4.38% | -17.5% |
Q2 2019 | $9,153,000 | +6.0% | 11,400,000 | +15.2% | 5.31% | +0.8% |
Q1 2019 | $8,638,000 | +7.1% | 9,900,000 | +12.5% | 5.27% | +15.6% |
Q4 2018 | $8,067,000 | -12.2% | 8,800,000 | 0.0% | 4.56% | -14.7% |
Q3 2018 | $9,187,000 | +2.0% | 8,800,000 | 0.0% | 5.34% | -31.0% |
Q2 2018 | $9,006,000 | +15.4% | 8,800,000 | +16.6% | 7.74% | +36.7% |
Q1 2018 | $7,804,000 | +71.9% | 7,550,000 | +43.8% | 5.66% | +110.0% |
Q4 2017 | $4,540,000 | +33.3% | 5,250,000 | +50.0% | 2.70% | +18.4% |
Q3 2017 | $3,405,000 | +252.8% | 3,500,000 | +250.0% | 2.28% | +232.1% |
Q2 2017 | $965,000 | – | 1,000,000 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 13,500,000 | $10,897,000 | 8.30% |
Context Capital Management, LLC | 11,400,000 | $9,153,000 | 5.31% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 36,525,000 | $29,507,000 | 1.49% |
WHITEBOX ADVISORS LLC | 24,250,000 | $19,409,000 | 0.68% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,000,000 | $23,854,000,000 | 0.46% |
IRON Financial LLC | 490,000 | $428,000 | 0.40% |
WOLVERINE ASSET MANAGEMENT LLC | 28,680,000 | $23,081,000 | 0.30% |
AQR Arbitrage LLC | 32,275,000 | $25,913,000 | 0.30% |
Telemetry Investments, L.L.C. | 300,000 | $240,000 | 0.18% |
CAPSTONE INVESTMENT ADVISORS, LLC | 9,500,000 | $7,627,000 | 0.06% |